MTOR and melanoma: Yang et al. [27] also reported that bornyl cis-4-hydroxycinnamate suppressed cell metastasis of melanoma by reducing the expressions of MMP-2 and MMP-9 through the FAK/PI3K/Akt/mTOR pathway [28, 29].